92 related articles for article (PubMed ID: 10772700)
1. Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state.
Painter GR; Andrews CW; Furman PA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):13-29. PubMed ID: 10772700
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
3. Kinetic evidence for interaction of human immunodeficiency virus type 1 reverse transcriptase with the 3'-OH of the incoming dTTP substrate.
Jamburuthugoda VK; Guo D; Wedekind JE; Kim B
Biochemistry; 2005 Aug; 44(31):10635-43. PubMed ID: 16060672
[TBL] [Abstract][Full Text] [Related]
4. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the conformations of the 5'-triphosphates of zidovudine (AZT) and thymidine bound to HIV-1 reverse transcriptase.
Painter GR; Aulabaugh AE; Andrews CW
Biochem Biophys Res Commun; 1993 Mar; 191(3):1166-71. PubMed ID: 7682061
[TBL] [Abstract][Full Text] [Related]
6. Interactions of conformationally biased north and south 2'-fluoro-2', 3'-dideoxynucleoside 5'-triphosphates with the active site of HIV-1 reverse transcriptase.
Mu L; Sarafianos SG; Nicklaus MC; Russ P; Siddiqui MA; Ford H; Mitsuya H; Le R; Kodama E; Meier C; Knispel T; Anderson L; Barchi JJ; Marquez VE
Biochemistry; 2000 Sep; 39(37):11205-15. PubMed ID: 10985766
[TBL] [Abstract][Full Text] [Related]
7. Metabolic transformation of AZTp4A by Ap4A hydrolase regenerates AZT triphosphate.
Pitcher WH; Kirby TW; DeRose EF; London RE
Antiviral Res; 2003 May; 58(3):227-33. PubMed ID: 12767470
[TBL] [Abstract][Full Text] [Related]
8. Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
Sarafianos SG; Das K; Ding J; Boyer PL; Hughes SH; Arnold E
Chem Biol; 1999 May; 6(5):R137-46. PubMed ID: 10322129
[TBL] [Abstract][Full Text] [Related]
9. NMR study of dideoxynucleotides with anti-human immunodeficiency virus (HIV) activity.
Reddy DV; Jagannadh B; Kunwar AC
J Biochem Biophys Methods; 1996 Feb; 31(3-4):113-21. PubMed ID: 8675954
[TBL] [Abstract][Full Text] [Related]
10. Understanding the mode of action of L-nucleosides as antiviral agents: a molecular modeling approach.
Lee K; Chong Y; Chu CK
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):385-8. PubMed ID: 11563052
[TBL] [Abstract][Full Text] [Related]
11. The production and evaluation of antibodies for enzyme immunoassay of AZTTP.
Akeb F; Creminon C; Grassi J; Guedj R; Duval D
Nucleosides Nucleotides Nucleic Acids; 2001 Mar; 20(3):243-50. PubMed ID: 11393400
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside inhibitors.
Cruchaga C; Odriozola L; Andréola M; Tarrago-Litvak L; Martínez-Irujo JJ
Biochemistry; 2005 Mar; 44(9):3535-46. PubMed ID: 15736963
[TBL] [Abstract][Full Text] [Related]
13. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase.
Meyer PR; Matsuura SE; Mian AM; So AG; Scott WA
Mol Cell; 1999 Jul; 4(1):35-43. PubMed ID: 10445025
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of HIV-1 reverse transcriptase by combinations of chain-terminating nucleotides.
Villahermosa ML; Martinez-Irujo JJ; Cabodevilla F; Santiago E
Biochemistry; 1997 Oct; 36(43):13223-31. PubMed ID: 9341211
[TBL] [Abstract][Full Text] [Related]
15. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
Kerr SG; Anderson KS
Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
[TBL] [Abstract][Full Text] [Related]
16. Gamma-phosphate-substituted 2'-deoxynucleoside 5'-triphosphates as substrates for DNA polymerases.
Arzumanov AA; Semizarov DG; Victorova LS; Dyatkina NB; Krayevsky AA
J Biol Chem; 1996 Oct; 271(40):24389-94. PubMed ID: 8798694
[TBL] [Abstract][Full Text] [Related]
17. Conformational properties of nucleotide-based template-competitive HIV-1 reverse transcriptase inhibitors: analysis of enzyme binding modes.
Lin W; Li K; Moore BM; Doughty MB
Nucleosides Nucleotides Nucleic Acids; 2003 Mar; 22(3):283-97. PubMed ID: 12816387
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous.
Wilson JE; Wright LL; Martin JL; Haire SE; Ray PH; Painter GR; Furman PA
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):20-30. PubMed ID: 8528729
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.
Crespan E; Locatelli GA; Cancio R; Hübscher U; Spadari S; Maga G
Antimicrob Agents Chemother; 2005 Jan; 49(1):342-9. PubMed ID: 15616314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
